Earlier this month, researchers at Mount Sinai Health System performed a study using 3D ultrasound vascular imaging to detect plaque buildup in arteries.
We are proud to announce that Centerline Biomedical has been chosen as a MedTech Innovator Top 50 showcase company! The 50 companies were chosen from nearly 600 applicants to the 2017 MedTech Innovator competition.
A few members of the Centerline Biomedical team recently attended the Advanced Design & Manufacturing (AD&M) Expo at the Huntington Convention Center in downtown Cleveland.
We are proud to announce that, on March 29th, 2017, Centerline Biomedical, Inc. was approved by the Ohio Third Frontier Commission for a $1.26M Commercial Acceleration Loan Fund (CALF), under the Ohio Third Frontier Program, managed by the State of Ohio’s Development Services Agency (DSA).
According to Health IT Outcomes, the increased adoption of minimally-invasive procedures, a rising aged population and the support of technology are only a few factors driving the incredible growth behind the medical device market.
November 15-19, 2016 marked the 44th Annual VEITHsymposium, a 5-day conference where vascular specialists gathered to learn about innovations in vascular disease treatment.
The Importance of Funding Medical Innovation in 2017
As we enter into 2017, we find it increasingly important that the topic of funding medical innovation remain top-of-mind with new policymakers.